
ADC are IV-dominant. Biology permits SC. Engineering blocks it. Our J Controlled Release perspective details what's needed: conjugation chemistry, high-conc formulations (>100 mg/mL), biomaterials, devices.
sciencedirect.com/science/articl…
@ERC_Research @laliguecancer @GustaveRoussy

English

















